3 takeaways from our daily meeting: Stocks teeter, an oil trim, obesity drug fast track

Every weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. ET. Here's a recap of Thursday's key moments. Stocks teeter Selling high, considering buying Quick mentions: LLY, COST 1. Stocks teeter Stocks swayed on Thursday after starting the week with sharp gains that puttered out by Wednesday.

We're eyeing Estee Lauder , which we believe will have a great next quarter, and Constellation Brands as stocks we could potentially buy into weakness. 3. Quick mentions: LLY, COST Here are updates on two Club names: The U.S. Food and Drug Administration fast tracked the approval process for Eli Lilly 's obesity treatment, which is already approved for type-2 diabetes. Jim reiterated his prediction that Tirzepatide could become "the greatest selling drug of all time.

Россия Последние новости, Россия Последние новости

Similar News:Вы также можете прочитать подобные новости, которые мы собрали из других источников новостей

We're trimming one of our oil stocks that's up again after the big OPEC+ production cutOur plan is to take this extra cash and recycle it into other stocks that haven't made as strong of a move this week. Can't wait for Tuttle's inverse jimcramer ETF that begins trading in December. Don’t listen to Cramer Oh yeah... (See the Solar-Powered Florida Town That Didn't Lose Power During Ian)
Источник: CNBC - 🏆 12. / 72 Прочитайте больше »

Stocks waver as dollar eases, oil steadies on OPEC+ deal By ReutersStocks waver as dollar eases, oil steadies on OPEC+ deal The Fed should stop raising interest rates Fire him first otherwise he will definitely bring worldwide recession..!! Let's goooo!!!! Take all of my fun coupons
Источник: Investingcom - 🏆 450. / 53 Прочитайте больше »